TSHA
Taysha Gene Therapies Inc
4.50$
-3.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 99.6% | 74.6% | 76.4% | 86.8% | 88.6% | 94.6% | |
| – | 97.1% | 69.7% | 69.6% | 83.3% | 86.7% | 93.1% | |
| – | 97.1% | 69.7% | 69.6% | 83.3% | 86.7% | 93.1% | |
| – | 0.1% | 23.7% | – | – | – | – | |
| 1,000.0% | 2.9% | 55.4% | 99.2% | 56.6% | 55.4% | 28.1% | |
| 1,000.0% | 2.8% | 24.2% | 49.7% | 21.3% | 16.4% | 7.7% | |
| – | – | – | 1.2% | 1.0% | 1.2% | – | |
| – | 0.8% | 10.2% | 8.7% | 3.7% | 2.2% | 1.8% | |
| – | – | 17.4% | 30.1% | 23.5% | 27.4% | 14.6% | |
| -900.0% | 97.1% | 44.6% | 0.8% | 43.4% | 44.6% | 71.9% | |
| -7,433.3% | -23.6% | -110.1% | -317.9% | -297.0% | -375.6% | -207.2% | |
| 246,616.1% | 6.8% | 17.6% | 34.8% | 67.2% | 156.0% | 93.1% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.